DNLI
Denali Therapeutics Inc
20.50$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | |
| 7,082.6% | – | – | – | – | – | – | – | – | – | – | 2.6% | 2,989.8% | |
| 100.0% | – | – | – | – | – | – | – | – | – | – | 97.4% | -2,889.8% | |
| 7,082.6% | – | – | – | – | – | – | – | – | – | – | 2,692.0% | 11,118.8% | |
| 1,998.8% | – | – | – | – | – | – | – | – | – | – | 1,006.7% | 4,016.0% | |
| 9,081.5% | – | – | – | – | – | – | – | – | – | – | 3,719.5% | 14,997.1% | |
| -8,981.5% | – | – | – | – | – | – | – | – | – | – | -3,622.1% | -15,058.2% | |
| -7,841.6% | – | – | – | – | – | – | – | – | – | – | -3,539.2% | -14,188.4% | |
| 178.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -7,841.6% | – | – | – | – | – | – | – | – | – | – | -3,539.2% | -14,191.2% | |
| -7,666.6% | – | – | – | – | – | – | – | – | – | – | -3,440.2% | -13,798.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.